Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-15 4:20 pm Purchase | 2024-11-12 | 13D | 23andMe Holding Co. ME | GSK plc | 1,983,025 9.500% | 1,983,025 (New Position) | Filing History |
| 2024-11-12 4:32 pm Purchase | 2024-09-30 | 13G | Wave Life Sciences Ltd. WVE | GSK plc | 16,775,691 11.200% | 16,775,691 (New Position) | Filing History |
| 2024-03-28 5:06 pm Unchanged | 2024-03-25 | 13D | Nkarta, Inc. NKTX | GSK plc | 3,161,432 4.500% | 0 (Unchanged) | Filing History |
| 2024-02-13 1:37 pm Purchase | 2023-12-31 | 13G | GSK plc GSK | DODGE & COX | 102,084,740 5.800% | 6,254,900 (+6.53%) | Filing History |
| 2024-02-09 4:18 pm Unchanged | 2024-02-07 | 13D | 23andMe Holding Co. ME | GSK plc | 1,983,024 11.200% | 0 (Unchanged) | Filing History |
| 2024-02-06 5:10 pm Purchase | 2023-12-31 | 13G | CureVac N.V. CVAC | GSK plc | 16,591,937 7.400% | 1,656,216 (+11.09%) | Filing History |
| 2024-02-06 5:07 pm Purchase | 2023-12-31 | 13G | Wave Life Sciences Ltd. WVE | GSK plc | 13,983,761 11.500% | 3,300,000 (+30.89%) | Filing History |
| 2024-01-19 4:20 pm Sale | 2024-01-19 | 13D | Haleon plc HLN | GSK plc | 385,320,110 4.200% | -352,812,612 (-47.80%) | Filing History |
| 2023-10-10 4:07 pm Sale | 2023-10-10 | 13D | Haleon plc HLN | GSK plc | 738,132,722 8.000% | -270,000,000 (-26.78%) | Filing History |
| 2023-09-11 4:37 pm Unchanged | 2023-09-11 | 13D | Haleon plc HLN | GSK plc | 1,008,132,722 10.900% | 0 (Unchanged) | Filing History |
| 2023-07-19 6:29 pm Unchanged | 2023-07-17 | 13D | Bicycle Therapeutics plc BCYC | GSK plc | 1,529,561 4.400% | 0 (Unchanged) | Filing History |
| 2023-05-16 5:27 pm Sale | 2023-05-16 | 13D | Haleon plc HLN | GSK plc | 1,008,132,722 10.900% | -187,187,388 (-15.66%) | Filing History |
| 2023-02-14 1:54 pm Purchase | 2022-12-31 | 13G | GSK plc GSK | DODGE & COX | 95,829,840 5.500% | 95,829,840 (New Position) | Filing History |
| 2023-02-06 4:06 pm Unchanged | 2022-12-31 | 13G | CVRx, Inc. CVRX | GSK plc | 1,007,583 4.900% | 0 (Unchanged) | Filing History |
| 2023-01-30 4:37 pm Purchase | 2023-01-23 | 13G | Wave Life Sciences Ltd. WVE | GSK plc | 10,683,761 10.950% | 10,683,761 (New Position) | Filing History |
| 2023-01-20 4:08 pm Unchanged | 2022-11-07 | 13D | 23andMe Holding Co. ME | GSK plc | 1,983,024 12.200% | 0 (Unchanged) | Filing History |
| 2023-01-20 4:08 pm Unchanged | 2022-11-14 | 13D | Spero Therapeutics, Inc. SPRO | GSK plc | 9,190,606 17.750% | 0 (Unchanged) | Filing History |
| 2022-11-14 5:02 pm Purchase | 2022-11-07 | 13D | Spero Therapeutics, Inc. SPRO | GSK plc | 9,190,606 19.990% | 7,450,000 (+428.01%) | Filing History |
| 2022-11-04 4:08 pm Purchase | 2021-06-16 | 13D | 23andMe Holding Co. ME | GSK plc | 1,983,024 13.200% | 1,983,024 (New Position) | Filing History |
| 2022-09-20 4:12 pm Sale | 2022-09-16 | 13D | Theravance Biopharma, Inc. TBPH | GSK plc | 0 0.000% | -9,644,807 (Position Closed) | Filing History |